[HTML][HTML] Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: guidance from the SSC of the ISTH

LN Roberts, V Hernandez‐Gea, M Magnusson… - Journal of Thrombosis …, 2022 - Elsevier
Hospital‐associated venous thromboembolism (HA‐VTE) is a major cause of morbidity and
mortality and is internationally recognized as a significant patient safety issue. While …

[HTML][HTML] Portal Vein Thrombosis: State-of-the-Art Review

A Boccatonda, S Gentilini, E Zanata, C Simion… - Journal of Clinical …, 2024 - mdpi.com
Background: Portal vein thrombosis (PVT) is a rare disease with an estimated incidence of 2
to 4 cases per 100,000 inhabitants. The most common predisposing conditions for PVT are …

[HTML][HTML] Biomarkers of liver dysfunction correlate with a prothrombotic and not with a prohaemorrhagic profile in patients with cirrhosis

MG Zermatten, M Fraga, DB Calderara, A Aliotta… - JHEP Reports, 2020 - Elsevier
Background & Aims Different liver dysfunction biomarkers are used to assess the bleeding
risk of patients with cirrhosis, either as such or included in bleeding risk assessment scores …

Venous Thromboembolism In Cancer Patients:“From Evidence to Care”

M Salgado, E Brozos-Vázquez… - Clinical and Applied …, 2022 - journals.sagepub.com
This article seeks to review the current status of treatment and prevention of venous
thromboembolic disease (VTE) in cancer patients after the addition of direct oral …

Coagulation defects in the cirrhotic patient undergoing liver transplantation

A Parker, CJ Karvellas - Transplantation, 2018 - journals.lww.com
Patients with cirrhosis undergoing liver transplantation have unique challenges with regard
to the prevention and management of thrombosis and hemorrhage. Patients with cirrhosis …

Who orders a head CT?: perceptions of the cirrhotic bleeding risk in an international, multispecialty survey study

LM Mazer, M Méan, EB Tapper - Journal of clinical …, 2017 - journals.lww.com
Objective: Traditional coagulopathic indices, including elevated international normalized
ratio, do not correlate with bleeding risk in patients with cirrhosis. For this reason, head …

Poremećaji hemostaze u bolesnika s cirozom jetre

M Majerović, A Boban, M Premužić, D Radić… - Liječnički …, 2016 - hrcak.srce.hr
Sažetak Do početka 90-ih godina prevladavalo je uvriježeno mišljenje da su bolesnici s
uznapredovalom jetrenom bolesti prirodno autoantikoagulirani i time zaštićeni od …